Bob Peterson has more than 34 years of experience formulating and executing regulatory, clinical, and product development strategies, interfacing with regulatory agencies and filing regulatory submissions for both the biopharmaceutical and medical device industries. He has extensive hands-on experience in R&D, manufacturing, nonclinical studies, and clinical studies as well as the preparation of regulatory submissions for each of these functional areas. Bob has led multiple meetings with the FDA and European Regulatory Agencies and has experience with special designations, negotiation of novel endpoints, and special protocol assessment. Bob’s therapeutic areas of expertise include chronic kidney disease, acute kidney injury, acute pain management, pulmonary hypertension, oncology, heart failure, vascular disease, cardiovascular disease, ocular angiogenesis, and regenerative medicine.
Prior to Halloran, Bob was the Executive Director of Regulatory Affairs for Liquidia Technologies, Inc. and the Vice President of Product Development and Regulatory Affairs for NephroGenex Inc. Earlier in his career, he was the Director of R&D for the Baxter cardiovascular group vascular division and held various positions within product development at other companies.
Bob earned a Bachelor of Science degree in Engineering at the United States Military Academy at West Point and a Master of Engineering degree in Biomedical Engineering at the University of California, Berkeley. Bob served as a Field Artillery Officer in the United States Army and has also received a Regulatory Affairs Certification.